Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human ...
EX937 utilizes a differentiated approach by inhibiting the FAAH enzyme, which increases the levels of Anandamide, an ...
Exxel Pharma to Participate in a "New to Virtual Investor" Segment
AURORA, CO / ACCESS Newswire / January 31, 2025 / Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated ...
Frontiers4 天
Current status and development prospects of aquatic vaccines
Diseases are a significant impediment to aquaculture’s sustainable and healthy growth. The aquaculture industry is suffering significant financial losses as a result of the worsening water quality and ...